Table 1 Clinicopathologic characteristics of the study population
From: Expression and prognostic value of circulating angiogenic cytokines in pancreatic cancer
| Â | n (%) or median (IQR) |
|---|---|
Total, n | 74 (100) |
Gender | Â |
   Male | 37 (50.0) |
   Female | 37 (50.0) |
Age [years] | 67.1 (58.7 - 70.7) |
Location of the tumor | Â |
   Pancreatic head | 54 (73.0) |
   Pancreatic body | 14 (18.9) |
   Pancreatic tail | 6 (8.1) |
CEA level [μg/l] | 2.9 (1.5 - 5.5) |
CA 19-9 level [μg/l] | 137.9 (33.8 - 558.9) |
Tumor size | Â |
   T1/2 | 2 (2.7) |
   T3 | 72 (97.3) |
Lymph node status | Â |
   Positive | 54 (73.0) |
   Negative | 20 (27.0) |
Resection margin status | Â |
   R0 | 27 (36.5) |
   R1 | 47 (63.5) |
Tumor differentiation | Â |
   Moderate (G2) | 48 (68.6) |
   Poor (G3) | 22 (31.4) |
Adjuvant therapy | Â |
   Yes | 49 (66.2) |
   No | 25 (33.8) |